NCT05305898 - "MetCool ACS- Metformin Cooling Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome" | Biotech Hunter

Enrollment

2,000

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Acute Coronary Syndrome

Interventions

DRUG

Metformin

"Patients from metformin group will receive metformin 3 x 850 mg (after titration period) for 2 years (3 x 500 mg for first 6 weeks) with 6 months follow-up after treatment cessation."

Trial Locations (14)

30-693

NOT_YET_RECRUITING

Oddział Kardiologii Szpitala św. Rafała, Krakow

66-400

NOT_YET_RECRUITING

Wielospecjalistyczny Szpital Wojewódzki w Gorzowie Wielkopolskim, Gorzów Wielkopolski

04-141

RECRUITING

Wojskowy Instytut Medyczny, Warsaw

46-200

NOT_YET_RECRUITING

Kluczborskie Centrum Kardiologii, Kluczbork

17-100

NOT_YET_RECRUITING

Centrum Kardiologii Scanmed w Bielsku Podlaskim, Bielsk Podlaski

41-500

NOT_YET_RECRUITING

Chorzowskie Centrum Kardiologii, Chorzów

47-400

NOT_YET_RECRUITING

Raciborskie Centrum Medyczne, Racibórz

41-219

NOT_YET_RECRUITING

Sosnowieckie Centrum Kardiologii, Sosnowiec

19-300

NOT_YET_RECRUITING

Centrum Kardiologii Scanmed w Ełku, Ełk

14-202

NOT_YET_RECRUITING

Centrum Kardiologii Scanmed w Iławie, Iława

78-400

NOT_YET_RECRUITING

Centrum Kardiologii Scanmed w Szczecinku, Szczecinek

99-320

NOT_YET_RECRUITING

Centrum Kardiologii Scanmed w Kutnie, Kutno

97-200

NOT_YET_RECRUITING

Centrum Kardiologii Scanmed w Tomaszowie Mazowieckim, Tomaszów Mazowiecki

42-200

NOT_YET_RECRUITING

Częstochowskie Centrum Kardiologii, Częstochowa